PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel imaging agent identifies biomarker for iron-targeted cancer therapies

Novel imaging agent identifies biomarker for iron-targeted cancer therapies
2021-07-23
(Press-News.org) Reston, VA--A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted therapies for cancer patients. The radiotracer, 18F-TRX, can be used to measure iron concentration in tumors, which can help predict whether a not the cancer will respond to treatment. This research was published in the July issue of the Journal of Nuclear Medicine.

All cancer cells have an insatiable appetite for iron, which provides them the energy they need to multiply. As a result, tumors have higher levels of iron than normal tissues. Recent advances in chemistry have led scientists to take advantage of this altered state, targeting the expanded cytosolic 'labile' iron pool (LIP) of the cancer cell to develop new treatments.

A clear method to measure LIP in tumors must be established to advance clinical trials for LIP-targeted therapies. "LIP levels in patient tumors have never been quantified," noted Adam R. Renslo, PhD, professor in the department of pharmaceutical chemistry at the University of California, San Francisco. "Iron rapidly oxidizes once its cellular environment is disrupted, so it can't be quantified reliably from tumor biopsies. A biomarker for LIP could help determine which tumors have the highest LIP levels and might be especially vulnerable to LIP-targeted therapies."

To explore a solution for this unmet need, researchers imaged 10 tissue graft models of glioma and renal cell carcinoma with 18F-TRX PET to measure LIP. Tumor avidity and sensitivity to the radiotracer were assessed. An animal model study was also conducted to determine effective human dosimetry.

18F-TRX showed a wide range of tumor accumulation, successfully distinguishing LIP levels among tumors and determining those that might be most likely to respond to LIP-targeted therapies. Pretreatment 18F-TRX uptake in tumors was also found to predict sensitivity to therapy. The estimated effective dose for adults was comparable to those of other 18F-based imaging agents.

"Iron dysregulation occurs in many human disorders, including neurodegenerative and cardiovascular diseases, and inflammation," said Michael J. Evans, associate professor in residence in the department of radiology and biomedical imaging at the University of California, San Francisco. "Applying 18F-TRX in the respective patient populations to define the extent of LIP expansion in affected tissues will be an important milestone toward understanding the therapeutic potential of LIP-targeted therapies beyond oncology."

INFORMATION:

This study was made available online in November 2020 ahead of final publication in print in July 2021.

The authors of "Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies" include Ning Zhao, Yangjie Huang, Yung-hua Wang, Ying-Chu Chen, Nima Hooshdaran, Junnian Wei, Pavithra Viswanath, Youngho Seo, Davide Ruggero, Adam R. Renslo and Michael John Evans, University of California, San Francisco, San Francisco, California; and Ryan K. Muir, Stanford University, Stanford, California.

Funding: This study was supported by an American Cancer Society research scholar grant (130635-RSG-17-005-01-CCE), the CDMRP Prostate Cancer Program (W81XWH-18-1-0763, W81XWH-16-1- 0435, and W81XWH1810754), and the National Institutes of Health (R01AI105106). Ryan Muir, Adam Renslo, and Michael Evans are listed as inventors on patent applications describing 18F-TRX and related radiotracers. Adam Renslo is a cofounder of and advisor to Tatara Therapeutics, Inc. No other potential conflict of interest relevant to this article was reported.

Visit JNM's new website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed.

Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org

About JNM and the Society of Nuclear Medicine and Molecular Imaging

The Journal of Nuclear Medicine (JNM) is the world's leading nuclear medicine, molecular imaging and theranostics journal, accessed more than 11 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of the Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.

JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging--precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit http://www.snmmi.org.


[Attachments] See images for this press release:
Novel imaging agent identifies biomarker for iron-targeted cancer therapies

ELSE PRESS RELEASES FROM THIS DATE:

Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma

Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma
2021-07-23
MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the efficacy of Loncastuximab tesirine, a promising new treatment for aggressive B-cell lymphoma. The results of the single-arm, phase 2 trial were published online in May 2021 in Lancet Oncology. Brian Hess, M.D., a Hollings researcher and lymphoma specialist at MUSC Health, was instrumental in bringing the phase 2 trial to Hollings. The manufacturer of Loncastuximab tesirine, ADC Therapeutics S.A., sponsored the trial. B-cell non-Hodgkin lymphoma (NHL) is a blood cancer that begins in the lymph nodes, spleen or bone marrow. Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of aggressive NHL. New treatment options are vital for patients with DLBCL. ...

Bio-based coating for wood outperforms traditional synthetic options

2021-07-23
Due to the global efforts to meet sustainability standards, many countries are currently looking to replace concrete with wood in buildings. France, for example, will require that all new public buildings will be made from at least 50 percent wood or other sustainable materials starting in 2022. Because wood is prone to degradation when exposed to sunlight and moisture, protective coatings can help bring wood into wider use. Researchers at Aalto University have used lignin, a natural polymer abundant in wood and other plant sources, to create a safe, low-cost and high-performing coating for use in construction. 'Our new coating has great potential to ...

Reverse optogenetic tool developed

2021-07-23
A new optogenetic tool, a protein that can be controlled by light, has been characterized by researchers at Ruhr-Universität Bochum (RUB). They used an opsin - a protein that occurs in the brain and eyes - from zebrafish and introduced it into the brain of mice. Unlike other optogenetic tools, this opsin is not switched on but rather switched off by light. Experiments also showed that the tool could be suitable for investigating changes in the brain that are responsible for the development of epilepsy. The teams led by Professor Melanie Mark from the Behavioural Neurobiology Research Group and Professor Stefan Herlitze from the Department ...

New 'atlas' charts how antibodies attack spike protein variants

2021-07-23
As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions of the virus. Vaccines against COVID-19, which were developed based on the chemistry and genetic code of this initial virus, may confer less protection if the antibodies they help people produce do not fend off new viral strains. Now, researchers from Brigham and Women's Hospital and collaborators have created an "atlas" that charts how 152 different antibodies attack a major ...

The impact of climate change on Kenya's Tana river basin

2021-07-23
Many species within Kenya's Tana River Basin will be unable to survive if global temperatures continue to rise as they are on track to do - according to new research from the University of East Anglia. A new study published in the journal PLOS ONE today outlines how remaining within the goals of the Paris Agreement would save many species. The research also identifies places that could be restored to better protect biodiversity and contribute towards global ecosystem restoration targets. Researcher Rhosanna Jenkins carried out the study as part of her PhD at UEA's School of Environmental Sciences. She said: "This research shows how many species within Kenya's Tana River Basin will be unable to survive if global temperatures continue to rise as they are on track to do. "But remaining ...

What's riskier for young soccer players, practice or game time?

2021-07-23
For young soccer players, participating in repetitive technical training activities involving heading during practice may result in more total head impacts but playing in scrimmages or actual soccer games may result in greater magnitude head impacts. That's according to a small, preliminary study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference, July 30-31, 2021. "Headers are a fundamental component to the sport of soccer. Therefore, it is important to understand differences in header frequency and magnitude across practice and game settings," said study author Jillian Urban, PhD, MPH, of Wake ...

Brain-repair discovery could lead to new epilepsy treatments

Brain-repair discovery could lead to new epilepsy treatments
2021-07-23
University of Virginia School of Medicine researchers have discovered a previously unknown repair process in the brain that they hope could be harnessed and enhanced to treat seizure-related brain injuries. Common seizure-preventing drugs do not work for approximately a third of epilepsy patients, so new and better treatments for such brain injuries are much needed. UVA's discovery identifies a potential avenue, one inspired by the brain's natural immune response. Using high-powered imaging, the researchers were able to see, for the first time, that immune cells called microglia were not just removing damaged material after experimental seizures but actually appeared to be healing damaged neurons. "There has been mounting generic support for the idea that microglia ...

Study shows environmental link to herbicide-resistant horseweed

Study shows environmental link to herbicide-resistant horseweed
2021-07-23
WESTMINSTER, Colorado - July 23, 2021 - Horseweed is a serious threat to both agricultural crops and natural landscapes around the globe. In the U.S., the weed is prolific and able to emerge at any time of the year. Fall emerging horseweed overwinters as a rosette, while spring emerging horseweed skips the rosette stage and grows upright. In some instances, both rosette and upright plants emerge simultaneously in mid-summer. These unpredictable growth patterns create challenges for growers as they try to develop an appropriate weed management plan. In a study featured in the journal Weed Science, a team from Michigan State University explored whether environmental cues could be used to predict horseweed growth ...

A new mathematical model assesses ICU patients' mortality risk

2021-07-23
A research team led by Dr Rosario Delgado from the UAB Department of Mathematics, in collaboration with the Hospital de Mataró, developed a new machine learning-based model that predicts the risk of mortality of intensive care unit patients according to their characteristics. The research was published in the latest edition of the journal Artificial Intelligence in Medicine, with a special mention as a "Position paper". Under the framework of Artificial Intelligence, machine learning allows a model to gain knowledge based on the information provided by available ...

Topology in biology

Topology in biology
2021-07-23
When can we say that a certain property of a system is robust? Intuitively, robustness implies that, even under the effect of external perturbations on the system, no matter how strong or random, said property remains unchanged. In mathematics, properties of an object that are robust against deformations are called topological. For example, the letters s, S, and L can be transformed into each other by stretching or bending their shape. The same holds true for letters o, O, and D. However, it is impossible to turn an S into an O without a discontinuous operation, such as cutting the O apart or sticking the two ends of the S together. Therefore, we say that the letters s, S and L have the same topology - as do the letters o, O and D - ...

LAST 30 PRESS RELEASES:

New study finds social programs could reduce the spread of HIV by 29%

SIDS discovery could ID babies at risk of sudden death

Ozone exposure linked to hypoxia and arterial stiffness

Princeton Chemistry develops copper-detection tool to discover possible chelation target for lung cancer

Drug candidate eliminates breast cancer tumors in mice in a single dose

WSU study shows travelers are dreaming forward, not looking back

Black immigrants attract white residents to neighborhoods

Hot or cold? How the brain deciphers thermal sensations

Green tea-based adhesive films show promise as a novel treatment for oral mucositis

Single-cell elemental analysis using Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

BioChatter: making large language models accessible for biomedical research

Grass surfaces drastically reduce drone noise making the way for soundless city skies

Extent of microfibre pollution from textiles to be explored at new research hub

Many Roads Lead to… the embryo

Dining out with San Francisco’s coyotes

What’s the mechanism behind behavioral side effects of popular weight loss drugs?

How employee trust in AI drives performance and adoption

Does sleep apnea treatment influence patients’ risk of getting into car accidents?

Do minimum wage hikes negatively impact students’ summer employment?

Exposure to stress during early pregnancy affects offspring into adulthood

Curious blue rings in trees and shrubs reveal cold summers of the past — potentially caused by volcanic eruptions

New frontiers in organic chemistry: Synthesis of a promising mushroom-derived compound

Biodegradable nylon precursor produced through artificial photosynthesis

GenEditScan: novel k-mer analysis tool based on next-generation sequencing for foreign DNA detection in genome-edited products

Survey: While most Americans use a device to monitor their heart, few share that data with their doctor

Dolphins use a 'fat taste' system to get their mother’s milk

Clarifying the mechanism of coupled plasma fluctuations using simulations

Here’s what’s causing the Great Salt Lake to shrink, according to PSU study

Can DNA-nanoparticle motors get up to speed with motor proteins?

Childhood poverty and/or parental mental illness may double teens’ risk of violence and police contact

[Press-News.org] Novel imaging agent identifies biomarker for iron-targeted cancer therapies